Candida albicans promotes invasion and colonisation of Candida glabrata in a reconstituted human vaginal epithelium

Journal of Infection

Volumn 69, Issue 4, 2014, Pages 396-407

  Alves, Carlos Tiago ^a   Wei, Xiao Qing ^b   Silva, Sónia ^a   Azeredo, Joana ^a   Henriques, Mariana ^a   Williams, David W ^b  

^a UNIVERSITY OF MINHO   (Portugal)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Candida albicans; Candida glabrata; Candidosis; Co infection; RHVE; Yeast PNA FISH

Indexed keywords

LACTATE DEHYDROGENASE; LYSOPHOSPHOLIPASE; PEPTIDE NUCLEIC ACID; PHOSPHOLIPASE D; VIRULENCE FACTOR; ALA1 PROTEIN, CANDIDA ALBICANS; CELL ADHESION MOLECULE; FUNGAL PROTEIN;

ALS GENE; ALS3 GENE; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CLINICAL EFFECTIVENESS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; EPA GENE; FEMALE; FUNGAL COLONIZATION; FUNGAL GENE; FUNGAL VIRULENCE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; HWP1 GENE; IN VITRO STUDY; MIXED INFECTION; NONHUMAN; ORGANISM HYBRIDIZATION; PATHOGENICITY; PLB GENE; PLD GENE; PLD1 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAP GENE; SPECIES COMPARISON; SPECIES INVASION; TISSUE ADHESION; VAGINA CANDIDIASIS; VAGINA EPITHELIUM; BACTERIAL COUNT; CANDIDIASIS; EPITHELIUM; GENETICS; METABOLISM; MICROBIOLOGY; TISSUE CULTURE TECHNIQUE; VAGINA;

CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; CELL ADHESION MOLECULES; COINFECTION; COLONY COUNT, MICROBIAL; EPITHELIUM; FEMALE; FUNGAL PROTEINS; HUMANS; TISSUE CULTURE TECHNIQUES; VAGINA;

EID: 84908539868     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.06.002     Document Type: Article

References (53)

1. Schuman P., Sobel J.D., Ohmit S.E., Mayer K.H., Carpenter C.C., Rompalo A., et al. Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) Group. Clin Infect Dis 1998, 27:1161-1167.
2. Pfaller M.A., Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007, 20:133-163.
3. De Leon E.M., Jacober S.J., Sobel J.D., Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis 2002, 2:1.
4. Sobel J.D., Faro S., Force R.W., Foxman B., Ledger W.J., Nyirjesy P.R., et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998, 178:203-211.
5. Anderson M.R., Klink K., Cohrssen A. Evaluation of vaginal complaints. JAMA 2004, 291:1368-1379.
6. Sobel J.D., Vaginitis N Eng J Med 1977, 1896-1903.
7. Trick W.E., Fridkin S.K., Edwards J.R., Hajjeh R.A., Gaynes R.P. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002, 35:627-630.
8. Fidel P.L., Vazquez J.A., Sobel J.D. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999, 12:80-96.
9. Silva S., Henriques M., Hayes A., Oliveira R., Azeredo J., Williams D.W. Candida glabrata and Candida albicans co-infection of an invitro oral epithelium. J Oral Pathol Med 2011, 40:421-427.
10. Kali A., Charles M.P., Noyal M.J., Sivaraman U., Kumar S., Easow J.M. Prevalence of Candida co-infection in patients with pulmonary tuberculosis. Australas Med J 2013, 6:387-391.
11. Martins M., Henriques M., Ribeiro A.P., Fernandes R., Gonçalves V., Seabra A., et al. Oral Candida carriage of patients attending a dental clinic in Braga, Portugal. Rev Iberoam Micol 2010, 27:119-124.
12. Belazi M., Velegraki A., Fleva A., Gidarakou I., Papanaum L., Baka D., et al. Candidal overgrowth in diabetic patients: potential predisposing factors. Mycoses 2005, 48:192-196.
13. Davies A.N., Brailsford S., Broadley K., Beighton D. Oral yeast carriage in patients with advanced cancer. Oral Microbiol Immunol 2002, 17:79-84.
14. Liguori G., Lucariello A., Colella G., De Luca A., Marinelli P. Rapid identification of Candida species in oral rinse solutions by PCR. J Clin Pathol 2007, 60:1035-1039.
15. Zaremba M.L., Daniluk T., Rozkiewicz D., Cylwik-Rokicka D., Kierklo A., Tokajuk G., et al. Incidence rate of Candida species in the oral cavity of middle-aged and elderly subjects. Adv Med Sci 2006, 51(Suppl. 1):233-236.
16. Qi Q.G., Hu T., Zhou X.D. Frequency, species and molecular characterization of oral Candida in hosts of different age in China. J Oral Pathol Med 2005, 34:352-356.
17. Naglik J.R., Moyes D., Makwana J., Kanzaria P., Tsichlaki E., Weindl G., et al. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology 2008, 154:3266-3280.
18. De Bernardis F., Lucciarini R., Boccanera M., Amantini C., Arancia S., Morrone S., et al. Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis. Infect Immun 2006, 74:4282-4294.
19. Cassone A., Boccanera M., Adriani D., Santoni G., Bernardis F. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect Immun 1995, 63:2619-2625.
20. De Bernardis F., Santoni G., Boccanera M., Spreghini E., Adriani D., Morelli L., et al. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect Immun 2000, 68:3297-3304.
21. Mestas J., Hughes C.C.W. Of mice and not men: differences between mouse and human immunology. J Immunol 2004, 172:2731-2738.
22. Jacobsen J., Nielsen E.B., Brøndum-Nielsen K., Christensen M.E., Olin H.B., Tommerup N., et al. Filter-grown TR146 cells as an invitro model of human buccal epithelial permeability. Eur J Oral Sci 1999, 107:138-146.
23. Moharamzadeh K., Brook I.M., Van Noort R., Scutt A.M., Smith K.G., Thornhill M.H. Development, optimization and characterization of a full-thickness tissue engineered human oral mucosal model for biological assessment of dental biomaterials. J Mater Sci Mater Med 2008, 19:1793-1801.
24. Yadev N.P., Murdoch C., Saville S.P., Thornhill M.H. Evaluation of tissue engineered models of the oral mucosa to investigate oral candidiasis. Microb Pathog 2011, 50:278-285.
25. Dongari-Bagtzoglou A., Kashleva H. Development of a highly reproducible three-dimensional organotypic model of the oral mucosa. Nat Protoc 2006, 1:2012-2018.
26. Schaller M., Zakikhany K., Naglik J.R., Weindl G., Hube B. Models of oral and vaginal candidiasis based on invitro reconstituted human epithelia. Nat Protoc 2006, 1:2767-2773.
27. Silva S., Henriques M., Oliveira R., Azeredo J., Malic S., Hooper S.J., et al. Characterization of Candida parapsilosis infection of an invitro reconstituted human oral epithelium. Eur J Oral Sci 2009, 117:669-675.
28. Yang Y.-L. Virulence factors of Candida species. J Microbiol Immunol Infect 2003, 36:223-228.
29. Calderone R., Gow N. Host recognition by Candida species. Candida and Candidiasis, Washington D. C 2002, 67-86. R. Calderone (Ed.).
30. Williams D.W., Wilson M.J., Lewis M.A., Potts A.J. Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA. J Clin Microbiol 1995, 33:2476-2479.
31. Skrzypek M.S., Arnaud M.B., Costanzo M.C., Inglis D.O., Shah P., Binkley G., et al. New tools at the Candida Genome Database: biochemical pathways and full-text literature search. Nucleic Acids Res 2010, 38:D428-D432.
32. Altschul S.F., Madden T.L., Schäffer A.A., Zhang J., Zhang Z., Miller W., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389-3402.
33. Rossignol T., Logue M.E., Reynolds K., Grenon M., Lowndes N.F., Butler G. Transcriptional response of Candida parapsilosis following exposure to farnesol. Antimicrob Agents Chemother 2007, 51:2304-2312.
34. Godaly G., Bergsten G., Hang L., Fischer H., Frendéus B., Lundstedt A.C., et al. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol 2001, 69:899-906.
35. Malic S., Hill K.E., Ralphs J.R., Hayes A., Thomas D.W., Potts A.J., et al. Characterization of Candida albicans infection of an invitro oral epithelial model using confocal laser scanning microscopy. Oral Microbiol Immunol 2007, 22:188-194.
36. Schaller M., Mailhammer R., Grassl G., Sander C.A., Hube B., Korting H.C. Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 2002, 118:652-657.
37. Jayatilake J.A.M.S., Samaranayake Y.H., Samaranayake L.P. An ultrastructural and a cytochemical study of candidal invasion of reconstituted human oral epithelium. J Oral Pathol Med 2005, 34:240-246.
38. Gow N.A.R. Fungal morphogenesis: some like it hot. Curr Biol 2009, 19:R333-R334.
39. Moyes D.L., Runglall M., Murciano C., Shen C., Nayar D., Thavaraj S., et al. A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells. Cell Host Microbe 2010, 8:225-235.
40. Sundstrom P., Balish E., Allen C.M. Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice. J Infect Dis 2002, 185:521-530.
41. Hornby J., Jensen E., Lisec A., Tasto J., Jahnke B., Shoemaker R., et al. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Env Microbiol 2001, 67:2982-2992.
42. Sheppard D.C., Yeaman M.R., Welch W.H., Phan Q.T., Fu Y., Ibrahim A.S., et al. Functional and structural diversity in the Als protein family of Candida albicans. J Biol Chem 2004, 279:30480-30489.
43. Argimón S., Wishart J.A., Leng R., Macaskill S., Mavor A., Alexandris T., et al. Developmental regulation of an adhesin gene during cellular morphogenesis in the fungal pathogen Candida albicans. Eukaryot Cell 2007, 6:682-692.
44. Hoyer L.L., Payne T.L., Bell M., Myers A.M., Scherer S. Candida albicans ALS3 and insights into the nature of the ALS gene family. Curr Genet 1998, 33:451-459.
45. Silva S., Negri M., Henriques M., Oliveira R., Williams D.W., Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 2012, 36:288-305.
46. Castaño I., Pan S.-J., Zupancic M., Hennequin C., Dujon B., Cormack B.P. Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata. Mol Microbiol 2005, 55:1246-1258.
47. Colombo A.L., Perfect J., DiNubile M., Bartizal K., Motyl M., Hicks P., et al. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. Eur J Clin Microbiol Infect Dis 2003, 22:470-474.
48. Niewerth M., Korting H.C. Phospholipases of Candida albicans. Mycoses 2001, 44:361-367.
49. Hube B., Hess D., Baker C.A., Schaller M., Schäfer W., Dolan J.W. The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans. Microbiology 2001, 147:879-889.
50. Ghannoum M.A. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000, 13:122-143.
51. Naglik J.R., Challacombe S.J., Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 2003, 67:400-428.
52. Schaller M., Borelli C., Korting H.C., Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005, 48:365-377.
53. Korting H.C., Hube B., Oberbauer S., Januschke E., Hamm G., Albrecht A., et al. Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium. J Med Microbiol 2003, 52:623-632.